VENUS MEDTECH
Venus MedTech (HangZhou) Inc. is located in Hangzhou National High-tech Industrial Development Zone (Binjiang), with its products positioned in the development and industrialization of international advanced interventional artificial cardiac valve system, filling up the blank in China. Interventional artificial aortic valve products researched and developed by the company takes the lead in finishing clinical tests in China. In reference to the development and promotion conditions of coronary stents at home and abroad, interventional artificial cardiac valve, as a revolutionary treatment means, has been increasingly recognized by experts, and will take on an explosible increase of clinical needs in the foreseeable next few years.
VENUS MEDTECH
Social Links:
Industry:
Health Care Industrial Medical Device
Founded:
2009-07-03
Address:
Hangzhou, Zhejiang, China
Country:
China
Website Url:
http://www.venusmedtech.com
Total Employee:
501+
Status:
Active
Contact:
0571-87772180
Email Addresses:
[email protected]
Total Funding:
69.39 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro SPF SSL By Default Font Awesome Apache Pound Sterling PHP Japanese Yen
Similar Organizations
Abu Dhabi Ports Company
Abu Dhabi Ports Company is a developer of ports and industrial zones.
Health2Sync
Health2Sync develops systems that transform smartphones into legacy medical devices and smart health monitoring machines.
Hong Kong Asia Heart Centre
Hong Kong Asia Heart Centre is a cardiovascular specialist chain that provides various cardiovascular assessment and surgical services.
Medtrum
Medtrum is a diabetes management medical device developer.
Nox Medical
Nox Medical, a part of Nox Health, is a global sleep health technology company
P3 Health Partners
P3 Health Partners is a patient-centered, physician-led and population health-focused healthcare company.
Seno Medical Instruments
Seno Medical is commercialization efforts in opto-acoustic imaging of breast cancer.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-12-07 | Cardiovalve | Cardiovalve acquired by Venus MedTech | 300 M USD |
| 2018-09-25 | Keystone Heart | Keystone Heart acquired by Venus MedTech | N/A |
| 2016-04-18 | Transcatheter Technologies | Transcatheter Technologies acquired by Venus MedTech | N/A |
Investors List
DCP Capital
DCP Capital investment in Private Equity Round - Venus MedTech
Qiming Venture Partners
Qiming Venture Partners investment in Series C - Venus MedTech
Goldman Sachs
Goldman Sachs investment in Series B - Venus MedTech
Goldman Sachs
Goldman Sachs investment in Venture Round - Venus MedTech
Qiming Venture Partners
Qiming Venture Partners investment in Series B - Venus MedTech
Qiming Venture Partners
Qiming Venture Partners investment in Series A - Venus MedTech
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-05-06 | Valgen Medtech | Venus MedTech investment in Series B - Valgen Medtech | 188 M USD |
Key Employee Changes
| Date | New article |
|---|---|
| 2022-03-18 | Venus Medtech appoints Shakeel Osman as Senior VP of Sales Europe to drive commercialization of TPVR system |
Official Site Inspections
http://www.venusmedtech.com Semrush global rank: 8.15 M Semrush visits lastest month: 628
- Host name: 121.14.65.215
- IP address: 121.14.65.215
- Location: China
- Latitude: 23.1167
- Longitude: 113.25
- Timezone: Asia/Shanghai
More informations about "Venus MedTech"
启明医疗-杭州启明医疗器械股份有限公司是中国领先的经导管心脏 …
启明医疗成立于2009年，位于杭州国家高新技术产业开发区（滨江），致力于结构性心脏病经导管治疗产品的研发和产业化。 公司已于2019年12月10日在香港联交所主板上市，股票代码 …See details»
ABOUT US-VENUS MEDTECH-
Venus Medtech (Hangzhou) Inc. ("Venus Medtech"), is the leader in transcatheter structural heart valvular therapies in China. The company is committed to the development and commercialization of innovative medical devices in the field …See details»
Corporate Governance - Venusmedtech
(Lin Haosheng) (林浩昇), aged 50, is an executive Director of our Company since December 15, 2023 and general manager of our Company since November 20, 2023. Mr. Lim joined the …See details»
Venus Medtech International | LinkedIn
Venus Medtech is a prominent player in transcatheter technologies for structural heart disease therapies. Our comprehensive solutions treat all four heart valves within the human heart …See details»
Venus Medtech - LinkedIn
A leading provider of integrated solutions for structural heart disease. Venus Medtech (Hangzhou) Inc. is a leading transcatheter heart valve medical device player in China in terms of...See details»
Venus MedTech - Crunchbase Company Profile & Funding
Venus MedTech is an national high-tech industrial development zone. View contacts for Venus MedTech to access new leads and connect with decision-makers.See details»
Public Disclosure - Venusmedtech
Aug 5, 2019 · Venus Medtech (Hangzhou) Inc., a leader in transcatheter heart valve therapies in China, develops and commercializes innovative medical devices for structural heart disease, …See details»
ANNUAL REPORT - ir.venusmedtech.com
杭州啓明醫療器械股份有限公司 Venus Medtech (Hangzhou) Inc. ANNUA L REPO RT 20 21 年度報 告 Venus_2021 AR Cover Size: 210 x 285 mm / Open Size: 451. ...See details»
Venus Medtech - Overview, News & Similar companies - ZoomInfo
Venus Medtech contact info: Phone number: +86 57186759022 Website: www.venusmedtech.com What does Venus Medtech do? Venus Medtech (Hangzhou) Inc. …See details»
Venus Medtech announces 2022 interim results: quality and …
On August 31, 2022, Venus Medtech (Hangzhou) Inc. (2500.HK, hereinafter referred to as "Venus Medtech"), a leading provider of integrated solutions for transcatheter structural heart valvular …See details»
Venus MedTech - Craft
Oct 29, 2024 · Venus MedTech (启明医疗) is a company that develops and commercializes transcatheter heart valve medical devices. It provides products designed for transcatheter …See details»
Venus Medtech Company Profile | Management and Employees …
Venus Medtech (Hangzhou) Inc. was founded in 2009 to focus on the design, development and commercialization of transcatheter heart valve products. The Company is the leading …See details»
Resources - Venusmedtech
Venus Medtech (Hangzhou) Inc., a leader in transcatheter heart valve therapies in China, develops and commercializes innovative medical devices for structural heart disease, …See details»
Venus Medtech Company Profile 2024: Stock Performance
Venus Medtech (Hangzhou) Inc is engaged in the development and commercialization of transcatheter solutions for structural heart diseases. It has two TAVR products on the market, …See details»
Venus Medtech VenusP-Valve Completed First Implantation in IDE …
Jun 14, 2024 · Venus Medtech (Hangzhou) Inc. (02500.HK) is committed to structural heart innovation. We are developing and commercializing comprehensive solutions for structural …See details»
Venus Medtech Venus-Vitae Completes First Two Implantations in …
Sep 5, 2024 · Following the first two successful implantations, Venus-Vitae SMART-ALIGN pivotal clinical trial will be progressively launched at around 20 centers in Europe, North America and …See details»
Venus Medtech announces 2021 annual results: pacesetter in …
Apr 1, 2022 · Venus Medtech boasts a best-in-class innovative cardiovascular device marketing team, which has by now expanded to 220 members. In 2021, the Company supported more …See details»
Venus Medtech announces 2020 annual results: Leading …
On March 31, 2021, Venus Medtech (Hangzhou) Inc. (02500.HK, hereinafter refers to as "Venus Medtech"), a leading provider of integrated solutions for transcatheter structural heart valvular …See details»
Venus Medtech VenusP-Valve transcatheter pulmonic valve …
Feb 5, 2024 · HK), a leading provider of integrated solutions for transcatheter structural heart valvular therapies in China, announced today that, VenusP-Valve, the company's in-house …See details»
Venus Medtech VenusP-Valve transcatheter pulmonic valve …
Hangzhou, China, Jan. 31, 2024 --Venus Medtech (02500. HK), a leading provider of integrated solutions for transcatheter structural heart valvular therapies in China, announced today that, …See details»